This is a subscriber-only article
Results from a clinical trial delivered by the Royal College of Surgeons, on behalf of animal nutrition company, Devenish, has proven that enriched omega-3 chicken and eggs reduces the risk of heart attack, stroke, dementia and depression.
The results of the six month trial were presented by Professor Alice Stanton of the Royal College of Surgeons to the American Heart Association this week.
The chicken and eggs used in the study came from birds offered an algae-based source of omega-3 which was developed by Devenish.
Professor Stanton said that Omega-3 enriched chicken and eggs offer consumers an attractive alternative to eating oily fish or taking supplements.
The health battle
Owen Brennan, executive chairman of Devenish, which invests £30m on research and development annually, said the company worked closely with Moy Park, Waitrose and the Royal College of Surgeons, to deliver a nutrient-rich food that increases omega-3 levels in consumers naturally.
He added that less than 20% of the world’s population eats enough Omega-3 and that farmers play a key role in delivering sustainable and nutritious food with a health claim.
It costs the health service £10bn every year to treat cardiovascular related illness according to Professor Chris Elliott, from the faculty of medicine, at Queens University Belfast.
SHARING OPTIONS: